Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Heart disease is responsible for about one-fourth of all deaths in India, and a fair share of these are caused by deaths occurring among women ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

The company shared interim results from an ongoing Phase II trial examining its recombinant antibody fusion protein.

A larger body doesn’t necessarily mean you have ‘clinical obesity’, according to a proposed new definition of the ...

Finally, a dancer cried out: "Stop the music!" A group of people rushed to the stage. Someone recognized that Hunter's heart had stopped. She was in cardiac arrest. One audience member started ...

Popular medications approved for weight loss, diabetes, and heart disease may have health benefits beyond weight loss, and blood sugar control, but there are risks too.

Neglecting high blood pressure can increase the risk of a very serious disease. High blood pressure doesn’t just affect your ...

However, the benefits of beta-blockers in “stiff heart” heart failure are less clear. This condition, also known as heart ...

About half of U.S. adults have high blood pressure, a major risk for heart attacks, strokes, kidney failure, even dementia.

Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...

Taken at face value, the results would suggest that the three SGLT2 inhibitors are "virtually identical," according to ...